Robot model
NaoTrac
Brain Navi Biotechnology (founded 2015 in Zhubei, Taiwan by the surgeon Jerry Chen) makes NaoTrac, a neurosurgical navigation robot that combines a robotic arm…
- Manufacturer
- Brain Navi
- Form factor
- surgical
- Maturity
- commercial
- Lifecycle
- active
- Deployments
- 2
Overview
Brain Navi Biotechnology (founded 2015 in Zhubei, Taiwan by the surgeon Jerry Chen) makes NaoTrac, a neurosurgical navigation robot that combines a robotic arm with AI-driven non-contact frameless registration to position instruments along pre-planned trajectories for procedures such as biopsy, tumor ablation, external ventricular drainage, stereo-electroencephalography, deep-brain stimulation, and endoscopy. It is a genuine surgical robot with a real robotic manipulator, and it has cleared its gating events across multiple jurisdictions, with Taiwan FDA approval in July 2022, a European CE mark, and US FDA 510(k) clearance in June 2025 as a stereotaxic guiding device. NaoTrac has the highest autonomy of the niche surgical set in this wave, since its AI-driven non-contact frameless registration is autonomous, but that autonomy lies in the navigation and registration step rather than in autonomous cutting or tissue manipulation, and the first-autonomous-neurosurgical-navigation-robot framing is a regulatory and marketing superlative. The registry records it at commercial, leaning early-commercial, maturity: it is cleared across Taiwan, Europe, and the US but remains a small startup with a limited and unverified installed base. For category context, Brainlab's Cirq robotic arm is a separate and legitimate surgical-robot candidate deferred to a follow-on wave, where the entity would be scoped to the Cirq arm rather than Brainlab's broader navigation-software portfolio.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Verified deployments
- 2 deployments on file
- Sources on file
- 3 sources, view all
Key facts
Form factor
Autonomy level
Regulatory approval
Maturity
Specs
Notes
Products
Form Factor
Fda clearance
Clearance body
Procedure types
Data & sources
Press releases
2
Web sources
1
3 sources backing this record.View all →
Pricing
No verified price is on record for NaoTrac. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Deployments (2)
- NaoTrac at Spainoperational
Following a demonstration at the SENEC (Spanish Society of Neurosurgery) Congress, a NaoTrac system was installed at a Spanish hospital in August 2025 and the country's first NaoTrac neurosurgery procedures were…
- NaoTrac at Rotterdamoperational
Erasmus MC in Rotterdam became the first site in the Netherlands to use the Brain Navi NaoTrac neurosurgical navigation robot, in July 2024.
NaoTrac on the deployment map
Where NaoTrac is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Verified media addedVerifiedJun 5, 2026
Brain Navi NaoTrac surgical navigation robot
- Record createdJun 3, 2026
Added to the verified registry
- Deployment verifiedVerifiedAug 11, 2025
at Spain
- Price point recordedJun 1, 2025
Not announced
- Deployment verifiedVerifiedJul 17, 2024
at Rotterdam
Deployment-verified media (1)
Brain Navi footage of its NaoTrac surgical-navigation robot for neurosurgery (presented at AANS 2025). Brain Navi markets NaoTrac as an 'Autopilot' and autonomous-navigation robot; this is the maker's claim.
From deployment: Spain
Regulatory filings (1)
- K242575fda 510k · us_fdacleared2025-05-23
Applicant: Brain Navi
Safety record
No incidents on record for NaoTrac.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (3)
Common questions
- What is NaoTrac?
- Brain Navi Biotechnology (founded 2015 in Zhubei, Taiwan by the surgeon Jerry Chen) makes NaoTrac, a neurosurgical navigation robot that combines a robotic arm with AI-driven non-contact frameless registration to position instruments along pre-planned trajectories for procedures such as biopsy, tumor ablation, external ventricular drainage, stereo-electroencephalography, deep-brain stimulation, and endoscopy. It is a genuine surgical robot with a real robotic manipulator, and it has cleared its gating events across multiple jurisdictions, with Taiwan FDA approval in July 2022, a European CE mark, and US FDA 510(k) clearance in June 2025 as a stereotaxic guiding device. NaoTrac has the highest autonomy of the niche surgical set in this wave, since its AI-driven non-contact frameless registration is autonomous, but that autonomy lies in the navigation and registration step rather than in autonomous cutting or tissue manipulation, and the first-autonomous-neurosurgical-navigation-robot framing is a regulatory and marketing superlative. The registry records it at commercial, leaning early-commercial, maturity: it is cleared across Taiwan, Europe, and the US but remains a small startup with a limited and unverified installed base. For category context, Brainlab's Cirq robotic arm is a separate and legitimate surgical-robot candidate deferred to a follow-on wave, where the entity would be scoped to the Cirq arm rather than Brainlab's broader navigation-software portfolio.
- How much does NaoTrac cost?
- NaoTrac's price is not publicly disclosed. DEPLOY has no verified price on record for NaoTrac from Brain Navi. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
- Is NaoTrac actually deployed in the real world?
- Yes. NaoTrac is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
- Is NaoTrac autonomous or teleoperated?
- Not verified as fully autonomous. NaoTrac's capabilities on the DEPLOY registry are recorded as teleoperated-assisted, demonstrated-only, or vendor claims (Assists surgery), not independently confirmed to run without a human in the loop.
- Who makes NaoTrac?
- NaoTrac is made by Brain Navi, based in Zhubei, Taiwan, founded in 2015.
- Where is NaoTrac deployed?
- 2 verified deployments of NaoTrac are on the DEPLOY registry, including at Spain, Rotterdam.
- Can you buy NaoTrac?
- NaoTrac is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
- Is NaoTrac FDA cleared?
- NaoTrac has 1 regulatory record on the DEPLOY registry: FDA 510(k) clearance (K242575), cleared. See the Regulatory filings section for each agency source.
- What are alternatives to NaoTrac?
- On the DEPLOY registry, comparable surgical robots to NaoTrac include Toumai, da Vinci (and Ion), Epione, Hugo RAS.
- How does NaoTrac compare to Toumai?
- NaoTrac and Toumai (MicroPort MedBot · 8 deployments) are both surgical robots on the DEPLOY registry. NaoTrac has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
- Is NaoTrac a top surgical?
- On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, NaoTrac ranks in roughly the top 42% of surgical models tracked by the registry.
- What is NaoTrac's maturity stage?
- NaoTrac is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
- Is NaoTrac safe?
- NaoTrac has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 3 sources (2 primary) · last reviewed 2026-07-12
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-07-12
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 2
- primary-company-ir
- Company IR disclosure
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for NaoTrac.Recent coverage
NaoTrac in third-party press
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning NaoTrac from third-party publications. Automatically surfaced; not part of the verified registry record.
Brain Navi achieves U.S. FDA approval for neurosurgical robot NaoTrac
Brain Navi Biotechnology, founded by surgeon Jerry Chen in Taiwan in 2015, received US FDA clearance for NaoTrac, its autonomous neurosurgical navigation robot.
Brain Navi achieves U.S. FDA approval for neurosurgical robot NaoTrac
Brain Navi received FDA clearance for the NaoTrac neurosurgical navigation robot, adding to existing Taiwan FDA and CE Mark approvals.
Brain Navi wins FDA nod for neurosurgical robot
Brain Navi, founded by surgeon Dr. Jerry Chen, won FDA clearance for its NaoTrac neurosurgical robot, already approved in Taiwan and CE marked.
Machine-readable surfaces
- Markdown mirror: /models/brain-navi-naotrac.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/f9d455c1-678b-4cf4-9a7d-37f593be85bc
- Revision history: /models/brain-navi-naotrac/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
NaoTrac draws attention at the 10th percentile but verifies reality at the 71st percentile among surgical robots. Hype Gap -61, 21st widest among surgical robots.
6-month trend
Analysis
Limited independent press and video coverage to date.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Jul 18, 2026